BellRing Brands posted Q3 earnings per share of $0.30, missing the $0.38 consensus estimate. The miss matters because the lower EPS, despite a 4% revenue increase, signals pressure on profitability and could weigh on the stock’s already steep 52.6% YTD decline.

Key Highlights

  • Operating profit hit $65.4 million and adjusted EBITDA $78.3 million, each reflecting a $10 million pre‑tax inventory charge.
  • EPS came in at $0.30 versus a $0.38 consensus, while net sales rose $22.9 million to $570.4 million.
  • Fiscal‑year sales outlook was updated to $2.335‑$2.375 billion, with adjusted EBITDA guidance set at $275‑$295 million.

Operating profit climbed to $65.4 million and adjusted EBITDA reached $78.3 million, both figures reflecting a $10 million pre‑tax inventory charge.

Q3 Results Beat Revenue, Miss EPS

BellRing reported EPS of $0.30 for the quarter ended June 30, 2026, against a $0.38 consensus estimate. Net sales rose $22.9 million to $570.4 million, driven by a 1.7% volume lift and a 2.5% price‑mix effect. Premier Protein contributed a 0.7% sales increase, while Dymatize surged 26.7% thanks to strong volume and price actions.

Despite the top‑line gain, the earnings shortfall highlights lingering cost pressures that could constrain future margins.

Revenue Drivers and Margin Pressure

The 4.2% sales rise stemmed from modest volume growth across the portfolio, but price‑mix headwinds eroded gross margin. Gross profit fell to $163.3 million, or 28.6% of sales, a $30.3 million decline from the prior period, as a $10 million excess‑inventory charge shaved 180 basis points off margin. Adjusted gross profit mirrored this trend at $157.9 million (27.7% of sales).

SG&A expenses trimmed to $93.7 million, lowering the expense ratio to 16.4% of sales, yet marketing spend climbed $6.7 million to $23.1 million to support Premier Protein. The net effect left operating profit at $65.4 million, underscoring the balance between cost cuts and margin erosion.

Market Reaction and Valuation Context

Sector peers showed modest gains, ELF up 4.4%, IPAR up 0.8%, and COTY up 1.1%, highlighting relative underperformance. The share price compression may present a risk‑reward scenario for value‑oriented investors seeking exposure to the protein‑shake niche.

Outlook and Upcoming Guidance

BellRing updated its fiscal‑year sales outlook to a range of $2.335‑$2.375 billion and set adjusted EBITDA expectations between $275 million and $295 million, incorporating a full‑year pre‑tax impact of $28 million. Management cited pricing actions, productivity initiatives, and disciplined cost management as levers to boost profitability moving forward. The company plans to revisit its guidance in the next quarterly earnings release, where analysts will gauge the effectiveness of these initiatives.

Peers Moving on This News

  • elf Beauty Inc (ELF) up 4.4%
  • Interparfums Inc (IPAR) up 0.8%
  • Coty Inc (COTY) up 1.1%

Analysis based on the Form 8-K filed 4 August 2026; figures verified against the filing and live market data.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.